Altria Increases Dividend for 57 Consecutive Years
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2026
0mins
Should l Buy MO?
Source: NASDAQ.COM
- Dividend Growth: Altria has increased its dividend for 57 consecutive years, currently boasting a 6.5% yield ($1.06 quarterly), ranking among the highest in the S&P 500, reflecting its strong commitment to shareholder returns.
- Market Challenges: Despite its impressive dividend record, the decline in U.S. adult smokers has led to falling volumes, forcing Altria to rely on price increases to offset this decline, a strategy that may not be sustainable in the long term.
- Investment Risks: Altria's attempts to establish a foothold in the smoke-free category have not yielded significant success, particularly with nearly $13 billion lost on its Juul investment and competition from Philip Morris International's Zyn, adding uncertainty to future growth prospects.
- Value Investment Opportunity: Despite these challenges, Altria is viewed as an ideal choice for value investors due to its strong cash flow and ongoing shareholder return strategies, making it particularly suitable for retirees seeking reliable income.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MO
Wall Street analysts forecast MO stock price to fall
8 Analyst Rating
4 Buy
3 Hold
1 Sell
Moderate Buy
Current: 73.090
Low
57.00
Averages
65.00
High
72.00
Current: 73.090
Low
57.00
Averages
65.00
High
72.00
About MO
Altria Group, Inc. operates a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products and oral tobacco products. The smokeable products segment consists of combustible cigarettes and machine-made large cigars. The oral tobacco products segment includes moist smokeless tobacco (MST) products and oral nicotine pouches. Its wholly owned subsidiaries include manufacturers of both combustible and smoke-free products. In combustibles, it owns Philip Morris USA Inc. (PM USA), and John Middleton Co. (Middleton), which are cigarette manufacturers. Its smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), a global MST manufacturer, Helix Innovations LLC (Helix), a manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio. The brand portfolios of its operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Surging Market Demand: Babcock & Wilcox (B & W) currently holds a $2.7 billion backlog, with $2.4 billion stemming from its partnership with Applied Digital, indicating a robust growth in power demand driven by the data center boom, which may lead to a revival of coal.
- Significant Stock Performance: B & W's stock has surged 244% over the past year, rising from below $1 to $21, reflecting optimistic market expectations for its future growth potential, despite facing controversies related to Applied Digital.
- Policy Support for Coal: President Trump and the Energy Secretary are actively working to prevent the closure of coal plants, viewing coal as a vital national security resource, which could provide new business opportunities for companies like B & W, despite ongoing environmental concerns.
- Changing Competitive Landscape: B & W possesses unique capabilities in building natural gas power plants, and with GE Vernova currently at capacity, B & W's expansion potential may position it favorably in the future energy market, particularly in the combined use of coal and natural gas.
See More
- Dividend Declaration: Altria (MO) has declared a quarterly dividend of $1.06 per share, consistent with previous payouts, demonstrating the company's ongoing ability to maintain stable cash flows and bolster investor confidence.
- Yield Performance: The forward yield stands at 5.9%, providing relative attractiveness in the current market environment, which may draw in income-seeking investors and further solidify its position in the consumer staples sector.
- Payment Arrangement: The dividend is payable on July 10, with a record date of June 15 and an ex-dividend date also on June 15, ensuring shareholders receive timely returns and reflecting the company's commitment to shareholder value.
- Market Reaction: Despite challenges posed by current inflationary pressures, Altria's ability to maintain dividend payments indicates financial robustness and confidence in future growth, potentially leading to positive impacts on its stock price.
See More
- CEO Transition: During the 2026 Annual Meeting, Altria announced Sal Mancuso as the new CEO, succeeding Billy Gifford, who served over 30 years, marking a significant step for the company's future direction under Mancuso's leadership.
- Preliminary Voting Results: At the Annual Meeting, all 10 nominees for the Board of Directors were elected for one-year terms, and PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2026, reflecting strong shareholder support for corporate governance.
- Quarterly Dividend Declaration: The Board declared a quarterly dividend of $1.06 per share, payable on July 10, 2026, to shareholders of record as of June 15, 2026, indicating the company's commitment to returning value to shareholders.
- Strategic Vision: Altria is committed to Moving Beyond Smoking® by responsibly transitioning to a smoke-free future and exploring new growth opportunities, demonstrating the company's proactive and responsible approach in a competitive market.
See More
- Significant Stock Growth: Altria's stock price has climbed to $69.21 over the past six months, reflecting a 20.3% increase that outperformed the S&P 500 by 12.6%, indicating strong market performance and investor confidence.
- Exceptional Gross Margin: With an average gross margin of 87.7% over the last two years, Altria demonstrates pricing power and product differentiation, allowing it to continually invest in brand and marketing initiatives.
- Strong Free Cash Flow: The company's free cash flow margin, averaging 42% in the consumer staples sector over the past two years, enables Altria to effectively reinvest and return capital to investors, maintaining its competitive edge.
- Long-Term Revenue Growth Challenges: Despite strong short-term performance, Altria's trailing 12-month sales of $20.38 billion are nearly flat compared to three years ago, highlighting challenges in sustaining long-term demand growth, prompting investors to carefully assess future growth potential.
See More
- Scotts Performance Risk: Scotts Miracle-Gro Company highlighted that poor weather conditions could adversely affect its performance, indicating a high sensitivity of its business to climate factors, which necessitates cautious risk assessment by investors.
- Santander Acquisition Praise: Banco Santander's acquisition of Webster Bank received positive feedback, with a former hedge fund manager praising it as a quality asset, reflecting confidence in the bank's future growth potential.
- Altria Stock Recommendation: Altria Group is advised to reduce holdings as analysts note its stock has surged too quickly, suggesting investors consider locking in some profits to mitigate risk.
- NextDecade's Outlook: NextDecade is viewed as having potential in LNG demand, although analysts maintain a cautious stance on its future performance, recommending investors to remain on the sidelines for now.
See More
- Policy Pressure: President Trump is reportedly pressuring FDA Commissioner Marty Makary to expedite the approval of flavored vapes and nicotine products, highlighting the urgency of his 2024 campaign promise to appeal to younger supporters.
- Health Concerns: Despite the pressure, Makary has expressed concerns about approving fruit flavors that may appeal to children, which could lead the FDA to only approve flavors like mint, coffee, tea, and spices that are deemed more adult-oriented, thereby affecting the variety of products in the market.
- Market Impact: Should the FDA approve flavored vapes, major tobacco companies such as British American Tobacco (BTI), Altria (MO), and Philip Morris International (PM) are likely to benefit, particularly Altria through its stake in Juul and the NJOY brand.
- Financial Outlook: Altria projects an adjusted diluted EPS of $5.56 to $5.72 for 2026, indicating that the company expects to achieve a more balanced performance between the first and second halves of the year.
See More











